李文烨, 翟纳, 巨修练, 刘根炎*. 黄嘌呤氧化酶抑制剂非布司他衍生物的研究进展J. 药学学报, 2021,56(12): 3401-3413. doi: 10.16438/j.0513-4870.2021-1032
引用本文: 李文烨, 翟纳, 巨修练, 刘根炎*. 黄嘌呤氧化酶抑制剂非布司他衍生物的研究进展J. 药学学报, 2021,56(12): 3401-3413. doi: 10.16438/j.0513-4870.2021-1032
LI Wen-ye, ZHAI Na, JU Xiu-lian, LIU Gen-yan*. Research progress of febuxostat derivatives as xanthine oxidase inhibitorsJ. Acta Pharmaceutica Sinica, 2021,56(12): 3401-3413. doi: 10.16438/j.0513-4870.2021-1032
Citation: LI Wen-ye, ZHAI Na, JU Xiu-lian, LIU Gen-yan*. Research progress of febuxostat derivatives as xanthine oxidase inhibitorsJ. Acta Pharmaceutica Sinica, 2021,56(12): 3401-3413. doi: 10.16438/j.0513-4870.2021-1032

黄嘌呤氧化酶抑制剂非布司他衍生物的研究进展

Research progress of febuxostat derivatives as xanthine oxidase inhibitors

  • 摘要: 黄嘌呤氧化酶抑制剂非布司他是经典的抗痛风药物,治疗效果显著且耐受性好。非布司他及其衍生物在结构上可以分为两个主要部分,分别为取代苯环和羧基取代的五元或六元杂环。本文综述了近10年来非布司他衍生物的研究进展,针对各类衍生物的构效关系进行了分类概述。探究黄嘌呤氧化酶抑制剂的作用机制和构效关系,对合理设计和开发抗痛风的新化学实体具有十分重要的意义。

     

    Abstract: Febuxostat, as a xanthine oxidase inhibitor, is a classic anti-gout drug with significant therapeutic effects and good tolerability. The structures of febuxostat and its derivatives can be divided into two parts:a substituted phenyl ring and a five-membered or six-membered heterocyclic ring with a carboxyl substitution. This paper reviewed the research progress of febuxostat derivatives in recent ten years and classified the structure-activity relationships of various febuxostat derivatives. Exploring the action mechanisms and structure-activity relationships of xanthine oxidase inhibitors might be significant for the rational design and development of new anti-gout chemical entities.

     

/

返回文章
返回